StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) KPIs and segments

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Neuraxis's business

Neuraxis's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q4 2023
Q3 2023
Q2 2023
Q4 2022
Q3 2022
Q2 2022
OH($M)
0.130.130.130.120.12
Canada($M)
0.090.140.160.140.080.12
WI($M)
0.070.020.090.110.130.17
FL($M)
0.050.040.050.050.070.10
All other States($M)
0.040.130.250.150.160.15
Israel($M)
0.020.05
Earlier reporting (last reported 2023)1

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-03-19.

See a number that looks wrong?